Castleark Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-54,440
| Closed | -$6.46M | – | 358 |
|
|
2022
Q1 | $6.46M | Buy |
54,440
+9,990
| +22% | +$1.18M | 0.28% | 88 |
|
|
2021
Q4 | $6.13M | Buy |
+44,450
| New | +$6.13M | 0.23% | 109 |
|
|
2021
Q1 | – | Sell |
-67,716
| Closed | -$5.8M | – | 387 |
|
|
2020
Q4 | $5.8M | Sell |
67,716
-60,245
| -47% | -$5.16M | 0.22% | 126 |
|
|
2020
Q3 | $8.32M | Buy |
127,961
+37,511
| +41% | +$2.44M | 0.33% | 91 |
|
|
2020
Q2 | $6.61M | Buy |
+90,450
| New | +$6.61M | 0.29% | 103 |
|
|
2019
Q3 | – | Sell |
-67,240
| Closed | -$2.94M | – | 418 |
|
|
2019
Q2 | $2.94M | Buy |
+67,240
| New | +$2.94M | 0.11% | 189 |
|